Go
View All
Pharmacologic Treatment of Social Phobia
Pharmacotherapies That Have Shown Promise for the Treatment of Stimulant Dependence
Pharmacotherapy for Obsessive-Compulsive Disorder (All Doses Listed Below Are mgs Per Day)
Physical Examination Items Deserving Special Attention
Predictors of Course and Outcome in Schizophrenia
Predisposing Biological and Psychosocial Factors
Prescreening Questions for Cognitive Testing
Prevalence of Substance-Use Disorders During the Previous Year (Per 100 Persons Aged 12 Years or Older)*
Prevalence of Substance Use in Last Month (Per 100 Persons Aged 12 Years or Older)
Prevalence Rate Estimates for Bulimia Nervosa
Principles of Management of Brief Psychotic Disorder
Principles of Management of Schizoaffective Disorder
Principles of Management of Shared Psychotic Disorder
Properties of Various Opioids
Psychiatric Assessment in ID/IDD: History
Psychiatric Assessment in ID/IDD: Patient Interview
Questions Related to a Developmental Orientation
Rating Scales Commonly Used in Assessing ADHD
Rating Scales for the Assessment of Oppositional/Aggressive Behavior
Relative Efficacy of Medication to Placebo in Preventing Relapse of Different Bipolarities in Maintenance Treatment of Bipolar Disorder as Monotherapy or Combination Therapy
Representative Tests Used to Evaluate Different Cognitive Functions at Various Ages
Research Diagnostic Criteria for Severe Mood Dysregulation (SMD)
Resources for Schizophrenia Genomics
Risk Factors for Schizophrenia
Risks for Potential Severe Side Effects from Commonly Used Antidepressants in Major Depressive Disorder
Safeguards Against the Dangers of Hospitalization
Screening Tests for Dissociative Disorders
Screening Tests for Office or Bedside Evaluation
Sections of the Mental Status Examination
Selected Catatonic Signs
Displaying items 121 - 150 of 185